Attention-Deficit/Hyperactivity Disorder Developmental Trajectories
... ADHD age 5–18 years at baseline and 10 –24 at follow-up. Again, differential ADHD developmental symptom trajectories were not examined. Moreover, maternal EE was assessed using two different structured clinical interviews at the two time points, neither initially designed to assess for EE. In additi ...
... ADHD age 5–18 years at baseline and 10 –24 at follow-up. Again, differential ADHD developmental symptom trajectories were not examined. Moreover, maternal EE was assessed using two different structured clinical interviews at the two time points, neither initially designed to assess for EE. In additi ...
Sleep in Older Adults
... elderly Half life 1-2.5 hrs Clinical dose 8mg No tolerance in 12 months studies, no withdrawal symptoms Adverse effects: somnolence, fatigue, dizziness, nausea Raehrs et a l 2012, Bastien et al 2011, Laudon et al. 2014 ...
... elderly Half life 1-2.5 hrs Clinical dose 8mg No tolerance in 12 months studies, no withdrawal symptoms Adverse effects: somnolence, fatigue, dizziness, nausea Raehrs et a l 2012, Bastien et al 2011, Laudon et al. 2014 ...
About ADHD
... Attention-deficit/hyperactivity disorder (ADHD) is a common behavioral condition affecting 11 percent of school-age children (Visser, et al., 2014). Symptoms continue into adulthood in more than three-quarters of cases (Brown, 2013). ADHD is characterized by developmentally inappropriate levels of i ...
... Attention-deficit/hyperactivity disorder (ADHD) is a common behavioral condition affecting 11 percent of school-age children (Visser, et al., 2014). Symptoms continue into adulthood in more than three-quarters of cases (Brown, 2013). ADHD is characterized by developmentally inappropriate levels of i ...
1 Selective serotonin reuptake inhibitors (SSRI) – sales, withdrawal
... the mental paralysis of melancholia”. Paris also mentions the time criteria as a problem for overdiagnosing, as two weeks is a short time scale and is not evidence based. The same goes for the cutoff point of 5 out of 9 criteria that should be fulfilled for the diagnosis dependence. It is unclear wh ...
... the mental paralysis of melancholia”. Paris also mentions the time criteria as a problem for overdiagnosing, as two weeks is a short time scale and is not evidence based. The same goes for the cutoff point of 5 out of 9 criteria that should be fulfilled for the diagnosis dependence. It is unclear wh ...
Tesis Doctoral
... psychosis, assuming that it could at least help to improve the course of illness, reducing its long-term impact (Corell et al., 2010). The possibility of studying psychosis in its early stages and exploring factors that might signal of vulnerability for psychosis onset and/or predict illness course ...
... psychosis, assuming that it could at least help to improve the course of illness, reducing its long-term impact (Corell et al., 2010). The possibility of studying psychosis in its early stages and exploring factors that might signal of vulnerability for psychosis onset and/or predict illness course ...
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder:
... and social phobia) will therefore be potentially applicable to adolescent patients. Similarly the recommendations are also likely to be pertinent to elderly patients although we did not specifically review evidence in those aged over 65 years. ...
... and social phobia) will therefore be potentially applicable to adolescent patients. Similarly the recommendations are also likely to be pertinent to elderly patients although we did not specifically review evidence in those aged over 65 years. ...
psychological behaviorism theory of bipolar disorder
... emotions (anger; irritability). This inclusion of two dysfunctional moods under one category is in contrast to the DSM-IV criteria for a major depressive episode in which one negative emotional state, dysphoria or loss of pleasure, is the defining dysfunctional mood characteristic. Heterogeneity is ...
... emotions (anger; irritability). This inclusion of two dysfunctional moods under one category is in contrast to the DSM-IV criteria for a major depressive episode in which one negative emotional state, dysphoria or loss of pleasure, is the defining dysfunctional mood characteristic. Heterogeneity is ...
zammit_NESS2011 - North East Sleep Society
... An Important Paradigm Shift: Recognition of chronic insomnia may influence research and clinical practice, with implications for long-term treatment NIH. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15 ...
... An Important Paradigm Shift: Recognition of chronic insomnia may influence research and clinical practice, with implications for long-term treatment NIH. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15 ...
Preview the material
... Bipolar disorder used to have another diagnostic category that was known as bipolar disorder not otherwise specified (NOS), which acted as something of a catch-all for symptoms that were not classified as bipolar I, bipolar II, or cyclothymic disorder. Furthermore, a patient could also be considere ...
... Bipolar disorder used to have another diagnostic category that was known as bipolar disorder not otherwise specified (NOS), which acted as something of a catch-all for symptoms that were not classified as bipolar I, bipolar II, or cyclothymic disorder. Furthermore, a patient could also be considere ...
Catatonia: a critical review and therapeutic
... Uncertainty about the nature and diagnostic relevance of catatonia certainly do not facilitate the recognition and correct interpretation of catatonic symptoms. Moreover, in industrialized countries classic catatonic manifestations such as immobility or negativism have become less frequent, and cata ...
... Uncertainty about the nature and diagnostic relevance of catatonia certainly do not facilitate the recognition and correct interpretation of catatonic symptoms. Moreover, in industrialized countries classic catatonic manifestations such as immobility or negativism have become less frequent, and cata ...
Catatonia: a critical review and therapeutic recommendations
... Uncertainty about the nature and diagnostic relevance of catatonia certainly do not facilitate the recognition and correct interpretation of catatonic symptoms. Moreover, in industrialized countries classic catatonic manifestations such as immobility or negativism have become less frequent, and cata ...
... Uncertainty about the nature and diagnostic relevance of catatonia certainly do not facilitate the recognition and correct interpretation of catatonic symptoms. Moreover, in industrialized countries classic catatonic manifestations such as immobility or negativism have become less frequent, and cata ...
- UM Students` Repository
... The prevalence of obsessive compulsive symptoms in the participants was 21.8% (N = 48) when YBOCS score cut off point of 8 and above were taken as clinically significant OCS. There were no significant difference in age, gender, race, marital status, education level, employment, family history of any ...
... The prevalence of obsessive compulsive symptoms in the participants was 21.8% (N = 48) when YBOCS score cut off point of 8 and above were taken as clinically significant OCS. There were no significant difference in age, gender, race, marital status, education level, employment, family history of any ...
NEUROFEEDBACK/BIOFEEDBACK FOR BEHAVIORAL AND
... this occurs, the individual’s EEG pattern is analyzed by qEEG, and an individualized feedback protocol is defined for the individual based on the reported findings. CLINICAL EVIDENCE Summary of Clinical Evidence The reviewed evidence does not clearly demonstrate a treatment effect of neurofeedback/b ...
... this occurs, the individual’s EEG pattern is analyzed by qEEG, and an individualized feedback protocol is defined for the individual based on the reported findings. CLINICAL EVIDENCE Summary of Clinical Evidence The reviewed evidence does not clearly demonstrate a treatment effect of neurofeedback/b ...
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical
... clinical question. On the other hand a narrative structure may be better suited to addressing clinical context, such as using a stepped care approach or choice between treatments. Deciding what questions to include in a question–and–answer format is a matter of opinion and will be influenced by the i ...
... clinical question. On the other hand a narrative structure may be better suited to addressing clinical context, such as using a stepped care approach or choice between treatments. Deciding what questions to include in a question–and–answer format is a matter of opinion and will be influenced by the i ...
Comparison of depressive episodes in bipolar disorder and in major
... have confirmed increased rates of major depressive disorder among the relatives of people with bipolar affective disorder,3–5 no report has compared the clinical characteristics of depression between these individuals and their relatives with bipolar disorder within the same pedigrees. Confirming di ...
... have confirmed increased rates of major depressive disorder among the relatives of people with bipolar affective disorder,3–5 no report has compared the clinical characteristics of depression between these individuals and their relatives with bipolar disorder within the same pedigrees. Confirming di ...
Treatment of Patients With Major Depressive
... The American Psychiatric Association (APA) Practice Guidelines are not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge ...
... The American Psychiatric Association (APA) Practice Guidelines are not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge ...
Research Paper Synthesis and Evaluation of Clozapine
... Schizophrenia and related psychosis, with abnormally high dopamine action apparently leading to these conditions. Numbers of drugs having the activity for blocking the neurotransmission of dopaminergic receptor in the central nervous system (Ross JB et al., 1996) have been developed. These include p ...
... Schizophrenia and related psychosis, with abnormally high dopamine action apparently leading to these conditions. Numbers of drugs having the activity for blocking the neurotransmission of dopaminergic receptor in the central nervous system (Ross JB et al., 1996) have been developed. These include p ...
(paroxetine hydrochloride) Controlled-Release Tablets
... Patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. PAXIL CR is not approved for use in pediatric patient ...
... Patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. PAXIL CR is not approved for use in pediatric patient ...
The World Federation of Societies of Biological Psychiatry (WFSBP
... also true for individual studies). In general, metaanalyses of negative primary data might identify a small effect size benefit as significant because of the power of Fisherian statistics. In order to achieve uniform and, in the opinion of this taskforce, appropriate ranking of evidence we adopted t ...
... also true for individual studies). In general, metaanalyses of negative primary data might identify a small effect size benefit as significant because of the power of Fisherian statistics. In order to achieve uniform and, in the opinion of this taskforce, appropriate ranking of evidence we adopted t ...
Evidence-based pharmacotherapy of panic
... long-term (follow-up periods up to 2 yr). Recently, a 6-month placebo-controlled discontinuation study found that time to relapse was significantly longer in the venlafaxine XR group than the placebo group (Ferguson et al. 2007). No studies investigating the long-term efficacy of phenelzine have been c ...
... long-term (follow-up periods up to 2 yr). Recently, a 6-month placebo-controlled discontinuation study found that time to relapse was significantly longer in the venlafaxine XR group than the placebo group (Ferguson et al. 2007). No studies investigating the long-term efficacy of phenelzine have been c ...
IOSR Journal Of Humanities And Social Science (IOSR-JHSS)
... improving aspects of insight in direct mode but few intervention namely cognitive skills training and psychoeducation(Nieznanski, Czerwinska, Chojnowska, Walczak, & Dunski, 2002) motivational interviewing and cognitive behavior therapy(Silver, 2003) has been used as an adjunct mode of effective opti ...
... improving aspects of insight in direct mode but few intervention namely cognitive skills training and psychoeducation(Nieznanski, Czerwinska, Chojnowska, Walczak, & Dunski, 2002) motivational interviewing and cognitive behavior therapy(Silver, 2003) has been used as an adjunct mode of effective opti ...
Read Full Article - Adult ADD ADHD Center of Maryland
... Attention-deficit/hyperactivity disorder (ADHD) in adults occurs at a prevalence rate that is higher than the prevalence of many major psychiatric disorders in adults. Thus, adult patients with ADHD often present with comorbid conditions, each of which alters the course of ADHD, overall treatment re ...
... Attention-deficit/hyperactivity disorder (ADHD) in adults occurs at a prevalence rate that is higher than the prevalence of many major psychiatric disorders in adults. Thus, adult patients with ADHD often present with comorbid conditions, each of which alters the course of ADHD, overall treatment re ...
A Short Course in Psychiatry
... symptoms, consequences, and possible stressors. All the while, you need to watch for hints of new territory that you also will need to cover. Learn as much as possible about your patient’s symptoms. Are they constant or do they come and go? If episodic, how often do they occur and with what intensit ...
... symptoms, consequences, and possible stressors. All the while, you need to watch for hints of new territory that you also will need to cover. Learn as much as possible about your patient’s symptoms. Are they constant or do they come and go? If episodic, how often do they occur and with what intensit ...
postpartum psychosis
... Sad mood, guilt, irritability, excessive worry, anxiety, or feelings of being overwhelmed Sleep problems (often insomnia), fatigue Symptoms or complaints in excess of, or without physical cause Discomfort around baby, or lack of feelings towards baby Loss of focus and concentration (may miss appoint ...
... Sad mood, guilt, irritability, excessive worry, anxiety, or feelings of being overwhelmed Sleep problems (often insomnia), fatigue Symptoms or complaints in excess of, or without physical cause Discomfort around baby, or lack of feelings towards baby Loss of focus and concentration (may miss appoint ...
RUNNING HEAD: SYMPTOMS OF HYPOCHONDRIA IN OCD
... improvement in hypochondriasis was associated with changes in metacognitive beliefs. Implications for treatment and future research is discussed. Keywords: hypochondriasis, obsessive-compulsive disorder, comorbidity, and metacognition. ...
... improvement in hypochondriasis was associated with changes in metacognitive beliefs. Implications for treatment and future research is discussed. Keywords: hypochondriasis, obsessive-compulsive disorder, comorbidity, and metacognition. ...
Antipsychotic
Antipsychotics (also known as neuroleptics or major tranquilizers) are a class of psychiatric medication primarily used to manage psychosis (including delusions, hallucinations, or disordered thought), in particular in schizophrenia and bipolar disorder, and are increasingly being used in the management of non-psychotic disorders (ATC code N05A). The word neuroleptic originates from the Greek word νεῦρον neuron (""nerve"") and λῆψις lepsis (""seizure"", ""fit"", ""occupation"").First-generation antipsychotics, known as typical antipsychotics, were discovered in the 1950s. Most second-generation drugs, known as atypical antipsychotics, have been developed more recently, although the first atypical antipsychotic, clozapine, was discovered in the 1950s and introduced clinically in the 1970s. Both generations of medication tend to block receptors in the brain's dopamine pathways, but atypicals tend to act on serotonin receptors as well.Antipsychotics are more effective than placebo in treating symptoms of psychosis, but some people do not respond fully or even partly to treatment. Their use is associated with significant side effects, most notably movement disorders and weight gain.